In one of its premiere transactions since the opening of the European Investment Bank’s regional office in Bulgaria in 2017, Spasov & Bratanov successfully advised the European Investment Bank in relation to a EUR 100,000,000 credit facility made available to Biovet AD – manufacturer and marketer of medicated and nutritional feed additives, part of the Huvepharma pharmaceutical group. Biovet AD will utilize the financing to fuel the construction of a new production plant in Peshtera, Bulgaria. It is expected that with the commissioning of the new facility in the end of this year, Biovet AD will create 150 new jobs in Peshtera and overall expand its production capabilities in Bulgaria with 50%. Allen & Overy acted as English and Luxemburg counsel with Spasov & Bratanov providing Bulgarian law advice on all aspects of the financing. This milestone transaction is yet another clear indicator of the leading position that the firms’ banking and finance practice enjoys on the Bulgarian market. Our highly experienced team consisted of Counsel Nadia Hadjova, assisted by Nayden and Irina.

Date: April 2018

Source: Spasov & Bratanov Lawyers’ Partnership


More Posts

Spasov & Bratanov successfully defended an individual against a claim for invalidity of the contract, on the basis of which this individual acquired interest in a limited liability company. The

Read More »

Spasov & Bratanov has advised Beijer Ref AB on all aspects of its entry into the Bulgarian market through the acquisition of a majority sharestake in Condex AD, a leading

Read More »

Spasov and Bratanov advised DBS Bank LTD, acting as arranger and Madison Pacific Trust Limited, acting as agent and security agent on making available certain facilities in excess of 1

Read More »

Spasov and Bratanov advised AES Bulgaria, the largest investor in the energy field in Bulgaria and one of the largest independent global energy producing companies, on borrowing Euro 150 million

Read More »